Related Experiment Videos
Pulse intravenous cyclophosphamide therapy for dermatologic disorders.
1Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, USA.
Dermatologic Clinics
|August 16, 2000
Summary
Pulse intravenous cyclophosphamide offers a promising, less toxic alternative for severe dermatologic conditions compared to oral administration. Further trials are needed to confirm long-term safety and efficacy.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Cyclophosphamide is a potent immunosuppressant used for various disorders.
- Oral cyclophosphamide has significant toxicities.
- Pulse intravenous cyclophosphamide shows promise for dermatologic conditions.
Purpose of the Study:
- To evaluate the efficacy and toxicity of pulse intravenous cyclophosphamide in dermatologic disorders.
- To compare the safety profile with oral cyclophosphamide therapy.
Main Methods:
- Review of studies on pulse intravenous cyclophosphamide for dermatologic diseases.
- Analysis of reported toxicities and efficacy.
Main Results:
- Pulse intravenous cyclophosphamide demonstrates efficacy in treating conditions like pemphigus vulgaris.
- Lower incidence of toxicity observed compared to oral cyclophosphamide.
- Short follow-up necessitates vigilance for side effects, including secondary malignancy.
Conclusions:
- Pulse intravenous cyclophosphamide is a viable option for severe, treatment-resistant dermatologic diseases.
- It presents an acceptable risk profile.
- Further prospective comparative trials are essential to fully assess its therapeutic potential and safety.